SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart ...
Marketwire (press release)
Neucardin is a genetically engineered recombinant peptide fragment of neuregulin-1 that has been clinically shown to directly improve cardiac function, reverse ventricular remodeling and increase the survival of heart failure patients. Six Phase 2 ...
SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed AccountingStreetInsider.com (subscription)

all 2 news articles »